NKTR — Nektar Therapeutics Share News
0.000.00%
- $1.32bn
- $692.66m
- $55.23m
Nektar Therapeutics Q1 net loss narrows on lower G&A costs
Brief: Nektar Therapeutics Q1 EPS USD -1.82
U.S. RESEARCH ROUNDUP-CME Group, GE Vernova, Texas Instruments
U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway
U.S. STOCKS ON THE MOVE-Certara, Otis, Twilio
U.S. STOCKS ON THE MOVE-Best Buy, Teleflex, Philip Morris
Nektar Therapeutics dips premarket after upsized $325 mln stock sale
Brief: Nektar Therapeutics Announces Pricing Of Upsized $325 Million Public Offering
Nektar starts $250 mln stock offering after alopecia treatment trial
Brief: Nektar Therapeutics Announces Proposed Public Offering
U.S. STOCKS ON THE MOVE-Adobe, Biogen, Sable
U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO
Nektar Therapeutics rises after alopecia treatment shows hair regrowth in study
U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen
NASDAQ RESUMED AT 09:00 AM
Nektar Therapeutics rises after alopecia treatment shows hair regrowth in study
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM
Nektar Therapeutics Q4 sales fall, hurt by lower royalty revenue
Brief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)